EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 122 participants.

Also called NCT06386874

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 122 participants (planned count) (from the registry)
Sponsor
BrainQ Technologies Ltd. (from the registry)
Registry
  • NCT NCT06386874
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06386874. Randomized; quadruple masking; primary purpose supportive care. Start 2024-08-20 (actual); primary completion 2026-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Intervention (Device)
Q Therapeutic System (BQ 3.0) - Sham
Intervention (Device)
Q Therapeutic System (BQ 3.0) - Active
Lead sponsor
BrainQ Technologies Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06386874
Content hash
9eb25088016aca738a0bf26ae1d88d468f934689ae2ca617178065b1fcb9d111